Pfizer Limited has officially announced upcoming changes within its Senior Management Personnel, effective in the first half of 2026. Mr. Deepak Rakheja will resign effective July 8, 2026. Separately, Mr. Anil Pattanshetty will transition to another Pfizer Group Company, ceasing his role as Senior Management Personnel effective March 31, 2026. The company provided formal notice to the stock exchanges on March 31, 2026.
Senior Management Transitions Confirmed
Pfizer Limited has formally communicated key changes affecting two members of its Senior Management Personnel, pursuant to mandatory disclosure requirements. The company issued this intimation on March 31, 2026, detailing the separation and transition dates for the involved executives.
Departure of Mr. Deepak Rakheja
Mr. Deepak Rakheja, currently serving as the Strategic Partnerships, Channel Development and International Neighbouring Markets Lead, has tendered his resignation. His cessation from services, and subsequently his role as Senior Management Personnel, will be effective close of business hours on July 8, 2026. Mr. Rakheja stated his intention to pursue opportunities external to Pfizer Limited.
Transition of Mr. Anil Pattanshetty
Mr. Anil Pattanshetty, the Senior Director of Business Operations, is slated to transition internally. He will move to another company within the broader Pfizer Group structure. Crucially, his tenure as Senior Management Personnel of Pfizer Limited will conclude one day prior to his internal group transition, effective on March 31, 2026 (close of business).
Formal Disclosure
The company confirmed that Mr. Rakheja’s resignation letter, meeting all requirements stipulated by recent circulars concerning disclosure timelines, was enclosed as Annexure A for completeness.
Source: BSE
